Challenges in SCLC research

Corinne Faivre-Finn, FRCR, MD, PhD of University of Manchester and the Christie NHS Foundation Trust, UK discusses challenges in small-cell lung cancer (SCLC) research. 10-15% of patients have SCLC, compared to over 20% ten years ago, which means there are less patients, who can be recruited to clinical trials. Another barrier is a lack of understanding of SCLC biology and genetic alterations, but research is ongoing in this field. Recorded at the 2016 National Cancer Research Institute (NCRI) Conference in Liverpool, UK.

Share this video